As of December 2024, Harvard Bioscience has a market cap of $90.07M. This makes Harvard Bioscience the world's 20665th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $201.17M | -11.92% |
2023 | $228.38M | 93.14% |
2022 | $118.25M | -60.71% |
2021 | $300.95M | 64.34% |
2020 | $183.13M | 40.66% |
2019 | $130.20M | -4.09% |
2018 | $135.75M | -3.64% |
2017 | $140.87M | 8.20% |
2016 | $130.20M | -12.10% |
2015 | $148.13M | -38.80% |
2014 | $242.04M | 20.64% |
2013 | $200.63M | 41.54% |
2012 | $141.75M | 13.18% |
2011 | $125.25M | -5.15% |
2010 | $132.05M | 14.29% |
2009 | $115.54M | 34.72% |
2008 | $85.76M | -42.14% |
2007 | $148.23M | -10.72% |
2006 | $166.03M | 15.28% |
2005 | $144.02M | -3.89% |
2004 | $149.85M | -47.98% |
2003 | $288.04M | 170.52% |
2002 | $106.48M | -66.90% |
2001 | $321.70M | - |